Annual Report 2019

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2019 91 The United Laboratories International Holdings Limited Annual Report 2019 5. REVENUE AND SEGMENT INFORMATION (Continued) Segment information (Continued) (b) Other segment information Amounts included in the measurement of segment profit or loss: For the year ended 31 December 2019 Intermediate Bulk Finished Unallocated products medicine products expenses Consolidated RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 Amortisation of intangible assets 1,840 – 10,767 – 12,607 Depreciation of right-of-use assets 71,293 2,018 1,387 – 74,698 Depreciation of property, plant and equipment 444,576 84,404 51,752 7,695 588,427 Net losses on disposal of property, plant and equipment 13,560 802 49 – 14,411 Impairment losses under expected credit loss model, net of reversal (1,376) 737 2,990 (10,006) (7,655)